Detalles de la búsqueda
1.
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.
N Engl J Med
; 384(19): 1810-1823, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33979489
2.
Identifying and addressing unmet clinical needs on the use of zanubrutinib in chronic lymphocytic leukemia: A consensus-based position paper from an ad hoc expert panel.
Hematol Oncol
; 42(2): e3255, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38362952
3.
An unusual form of BRAF-V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine.
Am J Hematol
; 99(3): 497-501, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38264797
4.
Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trial.
Am J Hematol
; 99(1): 57-67, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38014779
5.
Preventive versus curative photobiomodulation for oral mucositis in patients with multiple myeloma undergoing hematopoietic stem cell transplantation: which approach is more effective?
Support Care Cancer
; 32(3): 208, 2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38438625
6.
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.
Br J Haematol
; 203(3): 416-425, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37580908
7.
Predicting lymphoma in Sjögren's syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording.
Rheumatology (Oxford)
; 62(4): 1586-1593, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36063040
8.
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia.
Blood
; 138(7): 571-583, 2021 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33889952
9.
Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus-based position paper from an ad hoc expert panel.
Hematol Oncol
; 41(5): 795-808, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37165730
10.
European Delphi panel to build consensus on tapering and discontinuing thrombopoietin receptor agonists in immune thrombocytopenia.
Platelets
; 34(1): 2170999, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36803535
11.
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression.
Blood
; 135(15): 1244-1254, 2020 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32006000
12.
Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute study.
Haematologica
; 107(2): 500-509, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34134469
13.
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study.
Br J Haematol
; 193(2): 386-396, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33618438
14.
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies.
Br J Haematol
; 195(3): 371-377, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34272724
15.
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
Blood
; 134(14): 1132-1143, 2019 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31292114
16.
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL.
Blood
; 133(9): 919-926, 2019 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30617197
17.
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma.
Invest New Drugs
; 39(4): 1028-1035, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33523334
18.
SF3B1-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation
Haematologica
; 106(12): 3125-3135, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33121237
19.
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia.
Haematologica
; 105(6): 1613-1620, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31582547
20.
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia.
Haematologica
; 105(2): 448-456, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31371416